πŸ‡ΊπŸ‡Έ FDA
Patent

US 11072618

Compounds, compositions and methods

granted A61PA61P1/04A61P17/02

Quick answer

US patent 11072618 (Compounds, compositions and methods) held by DENALI THERAPEUTICS INC. expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DENALI THERAPEUTICS INC.
Grant date
Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/04, A61P17/02, A61P17/06, A61P19/02